新生血管性年龄相关性黄斑变性患者的肉碱穿梭通路发生改变
该研究对100例新生血管性年龄相关性黄斑变性(NVAMD)患者和192例对照者的血浆进行代谢组学分析,发现159个代谢特征可区分NVAMD与对照(AUC 0.83),其中肉碱穿梭通路显著改变(P=0.0001),五种酰基肉碱中间体经串联质谱确认在NVAMD患者中升高。聚类分析显示51%的NVAMD患者代谢谱相似,其余49%变异较大。
要点
- 血浆代谢组学可区分NVAMD患者与对照,AUC为0.83。
- 肉碱穿梭通路在NVAMD患者中显著改变(P=0.0001)。
- 五种肉碱穿梭通路酰基肉碱中间体在NVAMD患者中升高。
核心结论
- 多种长链酰基肉碱在NVAMD患者中显著升高,提示脂肪酸代谢可能参与NVAMD病理生理。
- 聚类分析提示临床不可区分的NVAMD患者可基于代谢谱分为不同亚组。
研究设计与样本
- 研究采用高分辨率C18液相色谱-质谱联用对100例NVAMD患者和192例对照者的血浆样本进行代谢组学分析。
- 质荷比采集范围为85至850,使用xMSanalyzer提取代谢特征。
- 采用嵌套特征选择识别区分NVAMD与对照的代谢物,用Mummichog 2.0进行通路分析,用层次聚类分析代谢物与分组的关系。
主要发现
- 在分析的10917个代谢特征中,识别出159个可区分NVAMD患者与对照的特征,曲线下面积为0.83。
- 159个特征中39个被注释,包含多种肉碱代谢物。
- 通路分析显示肉碱穿梭通路在NVAMD患者中显著改变(P=0.0001)。
- 串联质谱确认五种肉碱穿梭通路酰基肉碱中间体在NVAMD患者中升高。
- 层次聚类分析显示51%的NVAMD患者代谢谱相似,其余49%代谢谱变异较大。
关键数值与推荐
- 区分NVAMD与对照的159个代谢特征的曲线下面积为0.83。
- 肉碱穿梭通路改变在NVAMD患者中的P值为0.0001。
- 51%的NVAMD患者具有相似的代谢谱,49%的NVAMD患者代谢谱变异较大。
临床怎么用
- 血浆代谢组学特征或有助于识别NVAMD患者,但尚未作为临床诊断工具。
- 肉碱穿梭通路和长链酰基肉碱可能为NVAMD的病理机制研究提供方向。
- 基于代谢谱的NVAMD亚组划分可能为未来个体化评估提供线索。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To identify metabolites and metabolic pathways altered in neovascular age-related macular degeneration (NVAMD). METHODS: We performed metabolomics analysis using high-resolution C18 liquid chromatography-mass spectrometry on plasma samples from 100 NVAMD patients and 192 controls. Data for mass/charge ratio ranging from 85 to 850 were captured, and metabolic features were extracted using xMSanalyzer. Nested feature selection was used to identify metabolites that discriminated between NVAMD patients and controls. Pathway analysis was performed with Mummichog 2.0. Hierarchical clustering was used to examine the relationship between the discriminating metabolites and NVAMD patients and controls. RESULTS: Of the 10,917 metabolic features analyzed, a set of 159 was identified that distinguished NVAMD patients from controls (area under the curve of 0.83). Of these features, 39 were annotated with confidence and included multiple carnitine metabolites. Pathway analysis revealed that the carnitine shuttle pathway was significantly altered in NVAMD patients (P = 0.0001). Tandem mass spectrometry confirmed the molecular identity of five carnitine shuttle pathway acylcarnitine intermediates that were increased in NVAMD patients. Hierarchical cluster analysis revealed that 51% of the NVAMD patients had similar metabolic profiles, whereas the remaining 49% displayed greater variability in their metabolic profiles. CONCLUSIONS: Multiple long-chain acylcarnitines that are part of the carnitine shuttle pathway were significantly increased in NVAMD patients compared to controls, suggesting that fatty acid metabolism may be involved in NVAMD pathophysiology. Cluster analysis suggested that clinically indistinguishable NVAMD patients can be separated into distinct subgroups based on metabolic profiles.
引用
- Mitchell SL, Uppal K, Williamson SM, et al. The Carnitine Shuttle Pathway is Altered in Patients With Neovascular Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2018. PMID: 30326066. doi:10.1167/iovs.18-25137
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。